Clinical Trials Logo
  1. Home
  2. Hormones
  3. NCT00342498
  4. Details
NCT00342498 Clinical Trial

Estrogen Receptor Gene Mutations

Hormones Clinical Trial

Official title:
Estrogen Receptor Gene Mutations

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00342498
Other study ID # 999994012
Secondary ID OH94-E-N012
Status Completed
Phase N/A
First received June 19, 2006
Last updated June 30, 2017
Start date January 12, 1994
Est. completion date June 17, 2008

Study information
Verified date June 17, 2008
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment.

Description:

We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date June 17, 2008
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - INCLUSION CRITERIA:

Patient is individual with estrogen insensitivity.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States University of Cincinnati Medical Center Cincinnati Ohio
United States NIEHS, Research Triangle Park Research Triangle Park North Carolina

Sponsors (1)
Lead Sponsor Collaborator
National Institute of Environmental Health Sciences (NIEHS)

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05022992 - Effects of a Single Bout of Resistance Training Session on Hormonal Response in Pre-pubertal and Pubertal Boys N/A
Terminated NCT04371978 - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 Phase 3
Completed NCT04862208 - Breakfast Consumption and Energy Balance in Active Adult Males N/A
Recruiting NCT01121783 - The Effect of Lactisole on the Responses to Glucose Solution N/A
Completed NCT03677336 - Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI Phase 4
Completed NCT04414488 - The Impact of Regional Anaesthesia on Hormone Levels in Thoracic Surgery.
Completed NCT04930224 - Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients
Completed NCT02858336 - CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study) N/A
Completed NCT05136742 - Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological Changes N/A
Recruiting NCT04326374 - Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency Phase 3
Completed NCT02781727 - A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) Phase 3
Active, not recruiting NCT05288166 - A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) Phase 3